ATE549638T1 - 13c-mr-bildgebung oder spektroskopie von zelltod - Google Patents

13c-mr-bildgebung oder spektroskopie von zelltod

Info

Publication number: ATE549638T1
Authority: AT; Austria
Prior art keywords: imaging; spectroscopy; cell death; pyruvate; relates
Prior art date: 2006-08-18

Application number

AT07808605T

Other languages

English (en)

Inventor

Kevin Brindle

Samuel Day

Mikko Kettunen

Original Assignee

Ge Healthcare As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-18

Filing date

2007-08-17

Publication date

2012-03-15

2007-08-17 Application filed by Ge Healthcare As filed Critical Ge Healthcare As

2012-03-15 Application granted granted Critical

2012-03-15 Publication of ATE549638T1 publication Critical patent/ATE549638T1/de

Links

230000030833 cell death Effects 0.000 title abstract 2
238000003384 imaging method Methods 0.000 title abstract 2
238000004611 spectroscopical analysis Methods 0.000 title 1
238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 abstract 1
238000000701 chemical imaging Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
LCTONWCANYUPML-VQEHIDDOSA-N pyruvic -2-13c acid Chemical compound C[13C](=O)C(O)=O LCTONWCANYUPML-VQEHIDDOSA-N 0.000 abstract 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/46—NMR spectroscopy
- G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4828—Resolving the MR signals of different chemical species, e.g. water-fat imaging

Landscapes

Physics & Mathematics (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
High Energy & Nuclear Physics (AREA)
Condensed Matter Physics & Semiconductors (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Physics & Mathematics (AREA)
Spectroscopy & Molecular Physics (AREA)
Radiology & Medical Imaging (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Surgery (AREA)
Biophysics (AREA)
Pathology (AREA)
Biomedical Technology (AREA)
Signal Processing (AREA)
Medical Informatics (AREA)
Optics & Photonics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Magnetic Resonance Imaging Apparatus (AREA)
Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

AT07808605T 2006-08-18 2007-08-17 13c-mr-bildgebung oder spektroskopie von zelltod ATE549638T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NO20063702		2006-08-18
PCT/NO2007/000286 WO2008020764A1 (en)	2006-08-18	2007-08-17	13c-mr imaging or spectroscopy of cell death

Publications (1)

Publication Number	Publication Date
ATE549638T1 true ATE549638T1 (de)	2012-03-15

Family

ID=38690525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07808605T ATE549638T1 (de)	2006-08-18	2007-08-17	13c-mr-bildgebung oder spektroskopie von zelltod

Country Status (8)

Country	Link
US (1)	US8951500B2 (de)
EP (1)	EP2052273B1 (de)
JP (1)	JP5363320B2 (de)
CN (1)	CN101506679B (de)
AT (1)	ATE549638T1 (de)
ES (1)	ES2381380T3 (de)
PL (1)	PL2052273T3 (de)
WO (1)	WO2008020764A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101505802A (zh) *	2006-08-18	2009-08-12	通用电气医疗集团股份有限公司	含有乳酸盐类和超极化的13c-丙酮酸盐的成像介质
EP2107887A1 (de) *	2006-12-08	2009-10-14	Molecular Image Inc.	Verfahren zur diagnose und überwachung von neurologischen erkrankungen mit magnetresonanz-verfahren
GB0713074D0 (en)	2007-07-05	2007-08-15	Univ London	A method of hyperpolarising a magnetic resonance agent
JP5868311B2 (ja) *	2009-04-02	2016-02-24	ジーイー・ヘルスケア・リミテッド	炎症又は感染の検出のための過分極１３ｃピルビン酸塩を含む磁気共鳴造影媒体の使用
WO2012027274A2 (en) *	2010-08-23	2012-03-01	The Regents Of The University Of California	Compositions and methods for imaging
WO2012145733A1 (en)	2011-04-22	2012-10-26	Vanderbilt University	Para-hydrogen polarizer
WO2014118258A1 (en)	2013-01-31	2014-08-07	Bracco Imaging Spa	Hyperpolarized esters as metabolic markers in mr
US20160296645A1 (en) *	2013-07-01	2016-10-13	Bracco Imaging S.P.A	Hyperpolarized 1-13c-1,1-bis(acetoxy(methyl))-2,2'-cyclopropane as metabolic marker for mr
EP2863229A1 (de)	2013-10-15	2015-04-22	Technische Universität München	pH-Biosensoren auf Basis von Verbindungen mit pH-sensiblen Enolgruppen zur Magnetresonanzbildgebung und Spektroskopie und deren Verwendungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4822816A (en) *	1987-04-10	1989-04-18	Oxycal Laboratories, Inc.	Compositions and methods for administering vitamin C
US6278893B1 (en) *	1998-01-05	2001-08-21	Nycomed Imaging As	Method of magnetic resonance imaging of a sample with ex vivo polarization of an MR imaging agent
JP2003508437A (ja) *	1999-08-30	2003-03-04	オキシカル・ラボラトリーズ・インク	選択的癌化学療法及び該療法用の組成物
CN101031811A (zh)	2004-07-30	2007-09-05	通用电气医疗集团股份有限公司	肿瘤成像方法
KR101249634B1 (ko)	2004-11-19	2013-04-01	지이 헬스케어 에이에스	과분극화 13ｃ-피루베이트를 사용한 심장 영상화 방법

2007
- 2007-08-17 PL PL07808605T patent/PL2052273T3/pl unknown
- 2007-08-17 AT AT07808605T patent/ATE549638T1/de active
- 2007-08-17 EP EP07808605A patent/EP2052273B1/de not_active Not-in-force
- 2007-08-17 JP JP2009524573A patent/JP5363320B2/ja not_active Expired - Fee Related
- 2007-08-17 CN CN2007800309297A patent/CN101506679B/zh not_active Expired - Fee Related
- 2007-08-17 US US12/376,470 patent/US8951500B2/en active Active
- 2007-08-17 ES ES07808605T patent/ES2381380T3/es active Active
- 2007-08-17 WO PCT/NO2007/000286 patent/WO2008020764A1/en not_active Ceased

Also Published As

Publication number	Publication date
ES2381380T3 (es)	2012-05-25
WO2008020764A1 (en)	2008-02-21
EP2052273B1 (de)	2012-03-14
CN101506679A (zh)	2009-08-12
US8951500B2 (en)	2015-02-10
CN101506679B (zh)	2013-03-06
JP5363320B2 (ja)	2013-12-11
US20100226859A1 (en)	2010-09-09
JP2010501482A (ja)	2010-01-21
EP2052273A1 (de)	2009-04-29
PL2052273T3 (pl)	2012-08-31

Similar Documents

Publication	Publication Date	Title
ATE549638T1 (de)	2012-03-15	13c-mr-bildgebung oder spektroskopie von zelltod
CY1121327T1 (el)	2020-05-29	Τροποποιημενα αντισωματα anti-il-23p19
CY1120961T1 (el)	2019-12-11	Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
NO20071127L (no)	2007-02-28	Triazoloftalaziner
EA201270553A1 (ru)	2012-09-28	Ингибиторы тирозинкиназы брутона
EA200901313A1 (ru)	2010-04-30	Ингибиторы тирозинкиназы брутона
ECSP078013A (es)	2008-04-28	Inhibidores heterocíclicos de mek y métodos de uso de ellos
CY1117721T1 (el)	2017-05-17	Κυτταρα προελευσης αμνιακου υγρου
PL2358756T3 (pl)	2017-06-30	Ludzkie przeciwciała o wysokim powinowactwie wobec pcsk9
MX338884B (es)	2016-05-04	Composiciones y metodos que comprenden variantes de proteasa.
CR20110066A (es)	2011-05-25	Anticuerpos monoclonales contra el factor tisular inhibidor de la via
EA201200323A1 (ru)	2012-09-28	Соединения и композиции, как ингибиторы протеинкиназы
ECSP10010344A (es)	2010-08-31	Azolilmetiloxiranos, su uso y agentes que los contienen
EA201170288A1 (ru)	2011-12-30	Оксабициклогептаны и оксабициклогептены, их получение и применение
EA201101520A1 (ru)	2012-09-28	Способы диагностики онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния
CY1109985T1 (el)	2014-09-10	Αναστολεις πρωτεασωματος και μεθοδοι χρησης αυτων
CL2007003622A1 (es)	2009-08-07	Anticuerpo monoclonal humano anti-cd19; composicion que lo comprende; y metodo de inhibicion del crecimiento de celulas tumorales.
DE602006015793D1 (de)	2010-09-09	Proteolipidmembran und lipidmembranen-biosensor
ITMO20050067A1 (it)	2006-09-24	Mezzi di illuminazione e metodo per ottenere mezzi di illuminazione.
EA201270325A1 (ru)	2012-11-30	Способы лечения саркомы с использованием эпиметаболической сдвигающей добавки (кофермента q10)
MX351889B (es)	2017-11-01	Composiciones y métodos anti-cxcr1.
GT200600112A (es)	2006-11-29	Composiciiones de tigeciclina y metodos de preparacion
EP2516624A4 (de)	2013-12-18	Zelllinie 3m
EA200701396A1 (ru)	2007-12-28	Триазолофталазины в качестве ингибиторов pde-2
ATE548050T1 (de)	2012-03-15	Diagnoseverfahren